The novel siRNA inclisiran and population health management.
- Published in:
- Prescriber, 2023, v. 34, n. 1, p. 33, doi. 10.1002/psb.2037
- By:
- Publication type:
- Article
Works matching IS 09596682 AND DT 2023 AND VI 34 AND IP 1
Results: 9
1
2
Ryeqo for the treatment of the symptoms of uterine fibroids.
- Published in:
- Prescriber, 2023, v. 34, n. 1, p. 31, doi. 10.1002/psb.2036
- By:
- Publication type:
- Article
3
Mpox: a new outbreak of a once exotic infection.
- Published in:
- Prescriber, 2023, v. 34, n. 1, p. 27, doi. 10.1002/psb.2035
- By:
- Publication type:
- Article
4
The highs and lows of prescribing and monitoring lithium safely.
- Published in:
- Prescriber, 2023, v. 34, n. 1, p. 23, doi. 10.1002/psb.2034
- By:
- Publication type:
- Article
5
NICE on the assessment and management of self‐harm.
- Published in:
- Prescriber, 2023, v. 34, n. 1, p. 21, doi. 10.1002/psb.2033
- By:
- Publication type:
- Article
6
New antidepressants: monoamines and beyond.
- Published in:
- Prescriber, 2023, v. 34, n. 1, p. 17, doi. 10.1002/psb.2032
- By:
- Publication type:
- Article
7
Prescribing Skills Assessment.
- Published in:
- Prescriber, 2023, v. 34, n. 1, p. 16, doi. 10.1002/psb.2031
- Publication type:
- Article
8
Choice and use of long‐acting reversible contraceptives.
- Published in:
- Prescriber, 2023, v. 34, n. 1, p. 9, doi. 10.1002/psb.2030
- By:
- Publication type:
- Article
9
The endless pressures on prescribing.
- Published in:
- Prescriber, 2023, v. 34, n. 1, p. 4, doi. 10.1002/psb.2029
- Publication type:
- Article